Education
About Us
Working with TipRanks
Follow Us
Kanya Rajangam Insider Profile
4 Followers
Kanya Rajangam, CMO at Nkarta, holds 119.98K shares in Senti Biosciences (Ticker: SNTI), holds 12.80K shares in Nkarta (Ticker: NKTX), holds ― shares in Turnstone Biologics Corp. (Ticker: TSBX). Most recently, Kanya Rajangam Bought ― shares of Senti Biosciences on Mar 11, 2025 for an estimated value of 74.25K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-11.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kanya Rajangam holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kanya Rajangam
Kanya Rajangam's Trading History
Nkarta
Jan 19, 2022
CMO
Uninformative Buy
―
$27.65K
Senti Biosciences
Mar 11, 2025
Pres. & Chief Med. & Dev. Off
Informative Buy
74.25K
$231.57K
Turnstone Biologics Corp.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Kanya Rajangam's performance on stock
You May Also Like
Kanya Rajangam insider profile FAQ
What is the percentage of profitable transactions made by Kanya Rajangam?
The percentage of profitable transactions made by Kanya Rajangam is 50%.
What is the average return per transaction made by Kanya Rajangam?
The average return per transaction made by Kanya Rajangam is -11.30%.
What stocks does Kanya Rajangam hold?
Kanya Rajangam holds: NKTX, SNTI, TSBX stocks.
What was Kanya Rajangam’s latest transaction?
Kanya Rajangam latest transaction was an Informative Buy of $74.25K.
What was Kanya Rajangam's most profitable transaction?
Kanya Rajangam’s most profitable transaction was an Informative Sell of SNTI stock on February 6, 2025. The return on the trade was 20.60%.
What is Kanya Rajangam's role in Nkarta?
Kanya Rajangam's role in Nkarta is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.